These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23846996)

  • 21. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ; McGue M; Iacono WG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Hazell P
    Australas Psychiatry; 2010 Dec; 18(6):556-9. PubMed ID: 21117844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up.
    Groenman AP; Oosterlaan J; Greven CU; Vuijk PJ; Rommelse N; Franke B; Hartman CA; Hoekstra PJ; Sergeant J; Faraone SV; Buitelaar J
    J Child Psychol Psychiatry; 2015 May; 56(5):521-9. PubMed ID: 25139331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants.
    Lambert NM; Hartsough CS
    J Learn Disabil; 1998; 31(6):533-44. PubMed ID: 9813951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.
    Gorman DA; Gardner DM; Murphy AL; Feldman M; Bélanger SA; Steele MM; Boylan K; Cochrane-Brink K; Goldade R; Soper PR; Ustina J; Pringsheim T
    Can J Psychiatry; 2015 Feb; 60(2):62-76. PubMed ID: 25886657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.
    Penzner JB; Dudas M; Saito E; Olshanskiy V; Parikh UH; Kapoor S; Chekuri R; Gadaleta D; Avedon J; Sheridan EM; Randell J; Malhotra AK; Kane JM; Correll CU
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):563-73. PubMed ID: 19877981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
    Mannuzza S; Klein RG; Truong NL; Moulton JL; Roizen ER; Howell KH; Castellanos FX
    Am J Psychiatry; 2008 May; 165(5):604-9. PubMed ID: 18381904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder.
    Yılmaz S; Bilgiç A; Hergüner S
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):158-60. PubMed ID: 24168715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulant ADHD medication and risk for substance abuse.
    Chang Z; Lichtenstein P; Halldner L; D'Onofrio B; Serlachius E; Fazel S; Långström N; Larsson H
    J Child Psychol Psychiatry; 2014 Aug; 55(8):878-85. PubMed ID: 25158998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.
    Biederman J; Wilens T; Mick E; Spencer T; Faraone SV
    Pediatrics; 1999 Aug; 104(2):e20. PubMed ID: 10429138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.
    Dalsgaard S; Østergaard SD; Leckman JF; Mortensen PB; Pedersen MG
    Lancet; 2015 May; 385(9983):2190-6. PubMed ID: 25726514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.
    Tzang RF; Chang YC; Tsai GE; Lane HY
    J Psychopharmacol; 2016 Oct; 30(10):976-82. PubMed ID: 27443598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment.
    Wilson JJ
    Am J Addict; 2007; 16 Suppl 1():5-11; quiz 12-3. PubMed ID: 17453602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.